Cell therapy holds great promise in treating the underlying causes of disease by focusing on ways to regenerate, repair and replace damaged cells in the body, ultimately improving clinical outcomes, enhancing patient quality of life and reducing health care costs.

One of the challenges facing cell therapy companies is establishing a cost-effective and reproducible method for the large-scale manufacturing of quality cell therapy products. At Terumo BCT, we believe that addressing this challenge early can protect the commercial viability of future cell therapies.

Terumo BCT provides a team of experienced scientists to help you optimize and transfer your current process to the Quantum® Cell Expansion System. The Quantum system is an automated cell culture platform that delivers these benefits:

Cell expansion protocols for a variety of cell types

The simplification of open, labor-intensive manual tasks

Process optimization to match the needs of each particular cell type

Protocol flexibility and process automation for a range of production scenarios, from benchtop research to current good manufacturing practice (cGMP) commercial manufacturing

From preclinical application to clinical trials or commercialization, whether your company is a startup or an industry leader, we look forward to supporting your process and helping you prepare for the road ahead.

Read about efficient manufacturing of mesenchymal stromal cells (MSCs) in the Quantum system

Read about the evaluation of the Quantum system as a platform to manufacture allogeneic cell therapies for clinical use